The University of Chicago Header Logo

Connection

Mark Lingen to Interferon Type I

Back to Details
This is a "connection" page, showing publications Mark Lingen has written about Interferon Type I.
Mark Lingen
Connection Strength
0.245
Interferon Type I
  1. SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck. Cell Rep. 2023 07 25; 42(7):112823.
    View in: PubMed
    Score: 0.184
  2. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Cancer Res. 1998 Dec 01; 58(23):5551-8.
    View in: PubMed
    Score: 0.033
  3. The transcriptional profile of coronary arteritis in Kawasaki disease. BMC Genomics. 2015 Dec 18; 16:1076.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.